CYduct Diagnostics (PK) Stock Price

0.00 (0.0%)
Volume 0.00
Bid Price 0.25
Ask Price 500.00
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
CYduct Diagnostics Inc (PK) CYDX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.2501 16:15:26
Open Price Low Price High Price Close Price Prev Close
0.2501 0.2501
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.25 - 1.56
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.2501 USD


Draw Mode:

CYduct Diagnostics Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.29M 5.14M 739.84k $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
34.00 $ - - - -

more financials information »

CYduct Diagnostics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.25010.25010.25010.250110.000.0%
3 Months0.25010.25010.25010.2501610.000.0%
6 Months0.72010.72010.250.6135821532-0.47-65.27%
1 Year0.801.560.250.9212452854-0.5499-68.74%
3 Years0.624.890.060.8641461,228-0.3699-59.66%
5 Years0.624.890.060.8641461,228-0.3699-59.66%

CYduct Diagnostics (PK) Description

CYduct Diagnostics, Inc., headquartered in Westport, Connecticut, develops, produces, and markets medical products for the assessment, identification, diagnosis and ultimately treatment of early-stage breast disease. CYduct will provide personalized risk assessment tools and help identify precancerous and cancerous lesions within the mammary ducts. The CYduct technology platforms will be single-use, proprietary, high-margin, high-volume suite of breast care products which assess, screen, detect, monitor and treat identifiable changes that distinguish variations in breast health. CYduct is committed to providing both women and clinicians with noninvasive and minimally invasive technology that will continue to accelerate the intraductal evolution and improvement in the ability to: 1) assess breast health risk, 2) monitor breast health, 3) identify the need for increased personalized risk surveillance and 4) provide the tools to monitor, diagnose/treat breast disease through visual examination (Breast Endoscopy) within the ductal system of the breast.

Your Recent History
CYduct Dia..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now